Alles Mark J is a director of Syros Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Syros Pharmaceuticals, Inc.
19 Sep 23
4
Syros Pharmaceuticals, Inc.
2 Jun 23
4
BIOMARIN PHARMACEUTICAL INC
24 May 23
4
BIOMARIN PHARMACEUTICAL INC
2 Nov 22
4
Syros Pharmaceuticals, Inc.
19 Sep 22
4
Turning Point Therapeutics, Inc.
17 Aug 22
4
Syros Pharmaceuticals, Inc.
2 Jun 22
4
BIOMARIN PHARMACEUTICAL INC
26 May 22
4
BIOMARIN PHARMACEUTICAL INC
5 Jan 22
3
BIOMARIN PHARMACEUTICAL INC
5 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Sep 23 | SYRS Syros Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,666 | 0.00 | 3,666 |
16 Sep 23 | SYRS Syros Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,666 | 0.00 | 5,334 |
1 Jun 23 | SYRS Syros Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 4,000 | 0.00 | 4,000 |
1 Jun 23 | SYRS Syros Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.7 | 6,000 | 22.20 k | 6,000 |
23 May 23 | BMRN Biomarin Pharmaceutical Inc. - Registered Shares | Common Stock | Grant | Acquire A | No | No | 0 | 4,190 | 0.00 | 15,095 |
31 Oct 22 | BMRN Biomarin Pharmaceutical Inc. - Registered Shares | Common Stock | Buy | Acquire P | No | No | 86.75 | 3,625 | 314.47 k | 10,905 |